Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Applied Materials, Inc. stock logo
AMAT
Applied Materials
$450.06
+0.1%
$397.25
$153.47
$462.40
$357.03B1.667.26 million shs8.55 million shs
Salesforce Inc. stock logo
CRM
Salesforce
$191.00
+8.4%
$180.77
$163.52
$276.80
$144.15B1.1412.39 million shs33.95 million shs
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
$134.43
-1.3%
$135.30
$104.46
$157.29
$169.13B0.315.80 million shs17.51 million shs
7 Stocks to Buy And Hold Forever Cover

Click the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Applied Materials, Inc. stock logo
AMAT
Applied Materials
+0.08%+4.14%+17.64%+20.89%+178.52%
Salesforce Inc. stock logo
CRM
Salesforce
+8.34%+5.92%+5.33%-1.78%-30.56%
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
-1.31%+0.05%+4.34%-9.75%+23.97%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Applied Materials, Inc. stock logo
AMAT
Applied Materials
$450.06
+0.1%
$397.25
$153.47
$462.40
$357.03B1.667.26 million shs8.55 million shs
Salesforce Inc. stock logo
CRM
Salesforce
$191.00
+8.4%
$180.77
$163.52
$276.80
$144.15B1.1412.39 million shs33.95 million shs
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
$134.43
-1.3%
$135.30
$104.46
$157.29
$169.13B0.315.80 million shs17.51 million shs
7 Stocks to Buy And Hold Forever Cover

Click the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Applied Materials, Inc. stock logo
AMAT
Applied Materials
+0.08%+4.14%+17.64%+20.89%+178.52%
Salesforce Inc. stock logo
CRM
Salesforce
+8.34%+5.92%+5.33%-1.78%-30.56%
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
-1.31%+0.05%+4.34%-9.75%+23.97%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Applied Materials, Inc. stock logo
AMAT
Applied Materials
2.77
Moderate Buy$470.134.46% Upside
Salesforce Inc. stock logo
CRM
Salesforce
2.63
Moderate Buy$257.9735.06% Upside
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
2.86
Moderate Buy$156.9316.73% Upside

Current Analyst Ratings Breakdown

Latest CRM, AMAT, and GILD Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/28/2026
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
DowngradeBuy (B)Buy (B-)
5/28/2026
Salesforce Inc. stock logo
CRM
Salesforce
DowngradeOverweightNeutral
5/28/2026
Applied Materials, Inc. stock logo
AMAT
Applied Materials
Set Price Target$575.00
5/28/2026
Salesforce Inc. stock logo
CRM
Salesforce
Reiterated RatingBuy$325.00
5/28/2026
Salesforce Inc. stock logo
CRM
Salesforce
Lower Price TargetOverweight$300.00 ➝ $290.00
5/28/2026
Salesforce Inc. stock logo
CRM
Salesforce
Reiterated RatingMarket Outperform
5/28/2026
Salesforce Inc. stock logo
CRM
Salesforce
Reiterated RatingMarket Outperform
5/28/2026
Applied Materials, Inc. stock logo
AMAT
Applied Materials
Reiterated RatingOverweight$575.00
5/28/2026
Salesforce Inc. stock logo
CRM
Salesforce
Lower Price TargetNeutral$188.00 ➝ $187.00
5/28/2026
Salesforce Inc. stock logo
CRM
Salesforce
Lower Price TargetBuy$250.00 ➝ $225.00
5/28/2026
Salesforce Inc. stock logo
CRM
Salesforce
Lower Price TargetUnderperform$194.00 ➝ $173.00
(Data available from 5/30/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Applied Materials, Inc. stock logo
AMAT
Applied Materials
$28.37B12.60$10.10 per share44.54$30.11 per share14.95
Salesforce Inc. stock logo
CRM
Salesforce
$42.83B3.65$17.73 per share10.77$41.84 per share4.56
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
$29.44B5.67$10.33 per share13.01$18.87 per share7.12
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Applied Materials, Inc. stock logo
AMAT
Applied Materials
$7.00B$10.6542.2628.541.2629.31%36.97%21.30%8/13/2026 (Estimated)
Salesforce Inc. stock logo
CRM
Salesforce
$7.46B$8.6422.1117.401.2318.73%18.72%9.76%N/A
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
$8.51B$7.3418.3114.03N/A30.99%48.19%18.28%8/6/2026 (Estimated)

Latest CRM, AMAT, and GILD Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/27/2026Q1 2027
Salesforce Inc. stock logo
CRM
Salesforce
$3.13$3.88+$0.75$2.42$11.05 billion$11.13 billion
5/14/2026Q2 2026
Applied Materials, Inc. stock logo
AMAT
Applied Materials
$2.68$2.86+$0.18$3.51$7.68 billion$7.91 billion
5/7/2026Q1 2026
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
$1.91$2.03+$0.12$1.61$6.91 billion$6.96 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Applied Materials, Inc. stock logo
AMAT
Applied Materials
$2.120.47%+14.87%19.91%8 Years
Salesforce Inc. stock logo
CRM
Salesforce
$1.760.92%N/A20.37%1 Years
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
$3.282.44%+3.04%44.69%10 Years

Latest CRM, AMAT, and GILD Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/28/2026
Salesforce Inc. stock logo
CRM
Salesforce
quarterly$0.441%6/11/20266/11/20267/2/2026
4/29/2026
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
quarterly$0.822.45%6/15/20266/15/20266/29/2026
3/12/2026
Applied Materials, Inc. stock logo
AMAT
Applied Materials
quarterly$0.530.5%5/21/20265/21/20266/11/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Applied Materials, Inc. stock logo
AMAT
Applied Materials
0.22
2.51
1.80
Salesforce Inc. stock logo
CRM
Salesforce
1.15
0.79
0.76
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
0.89
1.97
1.77

Institutional Ownership

CompanyInstitutional Ownership
Applied Materials, Inc. stock logo
AMAT
Applied Materials
80.56%
Salesforce Inc. stock logo
CRM
Salesforce
80.43%
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
83.67%

Insider Ownership

CompanyInsider Ownership
Applied Materials, Inc. stock logo
AMAT
Applied Materials
0.30%
Salesforce Inc. stock logo
CRM
Salesforce
3.50%
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
0.30%
CompanyEmployeesShares OutstandingFree FloatOptionable
Applied Materials, Inc. stock logo
AMAT
Applied Materials
36,500793.96 million791.58 millionOptionable
Salesforce Inc. stock logo
CRM
Salesforce
83,334818.22 million789.58 millionOptionable
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
17,0001.24 billion1.24 billionOptionable

Recent News About These Companies

Norges Bank Takes Position in Gilead Sciences, Inc. $GILD

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Applied Materials stock logo

Applied Materials NASDAQ:AMAT

$450.06 +0.38 (+0.08%)
Closing price 05/29/2026 04:00 PM Eastern
Extended Trading
$449.35 -0.71 (-0.16%)
As of 05/29/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Applied Materials, Inc. engages in the provision of manufacturing equipment, services, and software to the semiconductor, display, and related industries. The company operates through three segments: Semiconductor Systems, Applied Global Services, and Display and Adjacent Markets. The Semiconductor Systems segment develops, manufactures, and sells various manufacturing equipment that is used to fabricate semiconductor chips or integrated circuits. This segment also offers various technologies, including epitaxy, ion implantation, oxidation/nitridation, rapid thermal processing, physical vapor deposition, chemical vapor deposition, chemical mechanical planarization, electrochemical deposition, atomic layer deposition, etching, and selective deposition and removal, as well as metrology and inspection tools. The Applied Global Services segment provides integrated solutions to optimize equipment and fab performance and productivity comprising spares, upgrades, services, remanufactured earlier generation equipment, and factory automation software for semiconductor, display, and other products. The Display and Adjacent Markets segment offers products for manufacturing liquid crystal displays; organic light-emitting diodes; and other display technologies for TVs, monitors, laptops, personal computers, electronic tablets, smart phones, and other consumer-oriented devices. It operates in the United States, China, Korea, Taiwan, Japan, Southeast Asia, and Europe. The company was incorporated in 1967 and is headquartered in Santa Clara, California.

Salesforce stock logo

Salesforce NYSE:CRM

$191.00 +14.83 (+8.42%)
Closing price 05/29/2026 03:59 PM Eastern
Extended Trading
$192.92 +1.92 (+1.01%)
As of 05/29/2026 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Salesforce, Inc. provides Customer Relationship Management (CRM) technology that brings companies and customers together worldwide. The company's service includes sales to store data, monitor leads and progress, forecast opportunities, gain insights through analytics and artificial intelligence, and deliver quotes, contracts, and invoices; and service that enables companies to deliver trusted and highly personalized customer support at scale. In addition, its platform offering comprise a flexible platform that enables companies of various sizes, locations, and industries to build business workflow and apps with customer; online learning platform that allows anyone to learn in-demand Salesforce skills; and Slack, an intelligent productivity platform. The company's marketing services enables companies to plan, personalize, automate, and optimize customer marketing journey, connecting interaction, and connected products; and commerce services, which empowers shopping experience across various customer touchpoint, such as mobile, web, social, and stores and provides click-to-code tools that offers customers to build and deploy solutions. Further, its analytics offering includes Tableau, an end-to-end analytics solution for range of enterprise use cases and intelligent analytics with AI models, spot trends, predict outcomes, creates summaries, timely recommendations, and take action from any device; and integration service including MuleSoft, which provides building blocks to deliver end-to-end and connected experiences. Additionally, the company provides data cloud, a hyperscale data engine native to Salesforce; vertical services to meet the needs of customers in industries, such as financial services, healthcare and life sciences, manufacturing and automotive and government; and offers salesforce starter for small and medium-sized businesses. Salesforce, Inc. was incorporated in 1999 and is headquartered in San Francisco, California.

Gilead Sciences stock logo

Gilead Sciences NASDAQ:GILD

$134.43 -1.79 (-1.31%)
Closing price 05/29/2026 04:00 PM Eastern
Extended Trading
$134.05 -0.38 (-0.28%)
As of 05/29/2026 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, Sunlencs, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of COVID-19; and Epclusa, Harvoni, Vemlidy, and Viread for the treatment of viral hepatitis. It also offers Yescarta, Tecartus, and Trodelvy products for the treatment of oncology; Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. The company has collaboration agreements with Arcus Biosciences, Inc.; Merck Sharp & Dohme Corp.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Dragonfly Therapeutics, Inc.; Arcellx, Inc.; Everest Medicines; Merck & Co, Inc.; Tentarix Biotherapeutics Inc.; and Assembly Biosciences, Inc. It also has research collaboration, option, and license agreement with Merus N.V. for the discovery of novel dual tumor-associated antigens (TAA) targeting trispecific antibodies. The company was incorporated in 1987 and is headquartered in Foster City, California.